Pharma & Healthcare
Global Boron-containing Compounds Drug Market Research Report 2026
- May 01, 26
- ID: 759805
- Pages: 110
- Figures: 110
- Views: 2
This report delivers a comprehensive overview of the global Boron-containing Compounds Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Boron-containing Compounds Drug. The Boron-containing Compounds Drug market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Boron-containing Compounds Drug market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Boron-containing Compounds Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Takeda Pharmaceutical
Janssen Pharmaceuticals
Pfizer
Hovione FarmaCiencia
Melinta Therapeutics
DC PHARMA
Gao Jin Biology
Neuboron
Segment by Type
Bortezomib
Tavaborole
Crisaborole
Vaborbactam-Meropenem
Ixazomib
Others
by Application
Multiple Myeloma
Toenail Fungal Infection
Atopic Dermatitis
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Boron-containing Compounds Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Boron-containing Compounds Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Boron-containing Compounds Drug market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Boron-containing Compounds Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Takeda Pharmaceutical
Janssen Pharmaceuticals
Pfizer
Hovione FarmaCiencia
Melinta Therapeutics
DC PHARMA
Gao Jin Biology
Neuboron
Segment by Type
Bortezomib
Tavaborole
Crisaborole
Vaborbactam-Meropenem
Ixazomib
Others
by Application
Multiple Myeloma
Toenail Fungal Infection
Atopic Dermatitis
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Boron-containing Compounds Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Boron-containing Compounds Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Boron-containing Compounds Drug Market Overview
1.1 Product Definition
1.2 Boron-containing Compounds Drug by Type
1.2.1 Global Boron-containing Compounds Drug Market Value by Type: 2025 vs 2032
1.2.2 Bortezomib
1.2.3 Tavaborole
1.2.4 Crisaborole
1.2.5 Vaborbactam-Meropenem
1.2.6 Ixazomib
1.2.7 Others
1.3 Boron-containing Compounds Drug by Application
1.3.1 Global Boron-containing Compounds Drug Market Value by Application: 2025 vs 2032
1.3.2 Multiple Myeloma
1.3.3 Toenail Fungal Infection
1.3.4 Atopic Dermatitis
1.3.5 Others
1.4 Global Boron-containing Compounds Drug Market Size Estimates and Forecasts
1.4.1 Global Boron-containing Compounds Drug Revenue 2021–2032
1.4.2 Global Boron-containing Compounds Drug Sales 2021–2032
1.4.3 Global Boron-containing Compounds Drug Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Boron-containing Compounds Drug Market Competition by Manufacturers
2.1 Global Boron-containing Compounds Drug Sales Market Share by Manufacturers (2021–2026)
2.2 Global Boron-containing Compounds Drug Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Boron-containing Compounds Drug Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Boron-containing Compounds Drug, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Boron-containing Compounds Drug, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Boron-containing Compounds Drug, Product Types and Applications
2.7 Global Key Manufacturers of Boron-containing Compounds Drug, Date of Entry into the Industry
2.8 Global Boron-containing Compounds Drug Market Competitive Situation and Trends
2.8.1 Global Boron-containing Compounds Drug Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Boron-containing Compounds Drug Players Market Share by Revenue
2.8.3 Global Boron-containing Compounds Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Boron-containing Compounds Drug Market Scenario by Region
3.1 Global Boron-containing Compounds Drug Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Boron-containing Compounds Drug Sales by Region: 2021–2032
3.2.1 Global Boron-containing Compounds Drug Sales by Region: 2021–2026
3.2.2 Global Boron-containing Compounds Drug Sales by Region: 2027–2032
3.3 Global Boron-containing Compounds Drug Revenue by Region: 2021–2032
3.3.1 Global Boron-containing Compounds Drug Revenue by Region: 2021–2026
3.3.2 Global Boron-containing Compounds Drug Revenue by Region: 2027–2032
3.4 North America Boron-containing Compounds Drug Market Facts & Figures by Country
3.4.1 North America Boron-containing Compounds Drug Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Boron-containing Compounds Drug Sales by Country (2021–2032)
3.4.3 North America Boron-containing Compounds Drug Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Boron-containing Compounds Drug Market Facts & Figures by Country
3.5.1 Europe Boron-containing Compounds Drug Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Boron-containing Compounds Drug Sales by Country (2021–2032)
3.5.3 Europe Boron-containing Compounds Drug Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Boron-containing Compounds Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Boron-containing Compounds Drug Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Boron-containing Compounds Drug Sales by Region (2021–2032)
3.6.3 Asia Pacific Boron-containing Compounds Drug Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Boron-containing Compounds Drug Market Facts & Figures by Country
3.7.1 Latin America Boron-containing Compounds Drug Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Boron-containing Compounds Drug Sales by Country (2021–2032)
3.7.3 Latin America Boron-containing Compounds Drug Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Boron-containing Compounds Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Boron-containing Compounds Drug Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Boron-containing Compounds Drug Sales by Country (2021–2032)
3.8.3 Middle East and Africa Boron-containing Compounds Drug Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Boron-containing Compounds Drug Sales by Type (2021–2032)
4.1.1 Global Boron-containing Compounds Drug Sales by Type (2021–2026)
4.1.2 Global Boron-containing Compounds Drug Sales by Type (2027–2032)
4.1.3 Global Boron-containing Compounds Drug Sales Market Share by Type (2021–2032)
4.2 Global Boron-containing Compounds Drug Revenue by Type (2021–2032)
4.2.1 Global Boron-containing Compounds Drug Revenue by Type (2021–2026)
4.2.2 Global Boron-containing Compounds Drug Revenue by Type (2027–2032)
4.2.3 Global Boron-containing Compounds Drug Revenue Market Share by Type (2021–2032)
4.3 Global Boron-containing Compounds Drug Price by Type (2021–2032)
5 Segment by Application
5.1 Global Boron-containing Compounds Drug Sales by Application (2021–2032)
5.1.1 Global Boron-containing Compounds Drug Sales by Application (2021–2026)
5.1.2 Global Boron-containing Compounds Drug Sales by Application (2027–2032)
5.1.3 Global Boron-containing Compounds Drug Sales Market Share by Application (2021–2032)
5.2 Global Boron-containing Compounds Drug Revenue by Application (2021–2032)
5.2.1 Global Boron-containing Compounds Drug Revenue by Application (2021–2026)
5.2.2 Global Boron-containing Compounds Drug Revenue by Application (2027–2032)
5.2.3 Global Boron-containing Compounds Drug Revenue Market Share by Application (2021–2032)
5.3 Global Boron-containing Compounds Drug Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Company Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Pharmaceutical Boron-containing Compounds Drug Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Janssen Pharmaceuticals
6.2.1 Janssen Pharmaceuticals Company Information
6.2.2 Janssen Pharmaceuticals Description and Business Overview
6.2.3 Janssen Pharmaceuticals Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Janssen Pharmaceuticals Boron-containing Compounds Drug Product Portfolio
6.2.5 Janssen Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer Boron-containing Compounds Drug Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Hovione FarmaCiencia
6.4.1 Hovione FarmaCiencia Company Information
6.4.2 Hovione FarmaCiencia Description and Business Overview
6.4.3 Hovione FarmaCiencia Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hovione FarmaCiencia Boron-containing Compounds Drug Product Portfolio
6.4.5 Hovione FarmaCiencia Recent Developments/Updates
6.5 Melinta Therapeutics
6.5.1 Melinta Therapeutics Company Information
6.5.2 Melinta Therapeutics Description and Business Overview
6.5.3 Melinta Therapeutics Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Melinta Therapeutics Boron-containing Compounds Drug Product Portfolio
6.5.5 Melinta Therapeutics Recent Developments/Updates
6.6 DC PHARMA
6.6.1 DC PHARMA Company Information
6.6.2 DC PHARMA Description and Business Overview
6.6.3 DC PHARMA Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 DC PHARMA Boron-containing Compounds Drug Product Portfolio
6.6.5 DC PHARMA Recent Developments/Updates
6.7 Gao Jin Biology
6.7.1 Gao Jin Biology Company Information
6.7.2 Gao Jin Biology Description and Business Overview
6.7.3 Gao Jin Biology Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Gao Jin Biology Boron-containing Compounds Drug Product Portfolio
6.7.5 Gao Jin Biology Recent Developments/Updates
6.8 Neuboron
6.8.1 Neuboron Company Information
6.8.2 Neuboron Description and Business Overview
6.8.3 Neuboron Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Neuboron Boron-containing Compounds Drug Product Portfolio
6.8.5 Neuboron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Boron-containing Compounds Drug Industry Chain Analysis
7.2 Boron-containing Compounds Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Boron-containing Compounds Drug Production Mode & Process Analysis
7.4 Boron-containing Compounds Drug Sales and Marketing
7.4.1 Boron-containing Compounds Drug Sales Channels
7.4.2 Boron-containing Compounds Drug Distributors
7.5 Boron-containing Compounds Drug Customer Analysis
8 Boron-containing Compounds Drug Market Dynamics
8.1 Boron-containing Compounds Drug Industry Trends
8.2 Boron-containing Compounds Drug Market Drivers
8.3 Boron-containing Compounds Drug Market Challenges
8.4 Boron-containing Compounds Drug Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Boron-containing Compounds Drug by Type
1.2.1 Global Boron-containing Compounds Drug Market Value by Type: 2025 vs 2032
1.2.2 Bortezomib
1.2.3 Tavaborole
1.2.4 Crisaborole
1.2.5 Vaborbactam-Meropenem
1.2.6 Ixazomib
1.2.7 Others
1.3 Boron-containing Compounds Drug by Application
1.3.1 Global Boron-containing Compounds Drug Market Value by Application: 2025 vs 2032
1.3.2 Multiple Myeloma
1.3.3 Toenail Fungal Infection
1.3.4 Atopic Dermatitis
1.3.5 Others
1.4 Global Boron-containing Compounds Drug Market Size Estimates and Forecasts
1.4.1 Global Boron-containing Compounds Drug Revenue 2021–2032
1.4.2 Global Boron-containing Compounds Drug Sales 2021–2032
1.4.3 Global Boron-containing Compounds Drug Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Boron-containing Compounds Drug Market Competition by Manufacturers
2.1 Global Boron-containing Compounds Drug Sales Market Share by Manufacturers (2021–2026)
2.2 Global Boron-containing Compounds Drug Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Boron-containing Compounds Drug Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Boron-containing Compounds Drug, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Boron-containing Compounds Drug, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Boron-containing Compounds Drug, Product Types and Applications
2.7 Global Key Manufacturers of Boron-containing Compounds Drug, Date of Entry into the Industry
2.8 Global Boron-containing Compounds Drug Market Competitive Situation and Trends
2.8.1 Global Boron-containing Compounds Drug Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Boron-containing Compounds Drug Players Market Share by Revenue
2.8.3 Global Boron-containing Compounds Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Boron-containing Compounds Drug Market Scenario by Region
3.1 Global Boron-containing Compounds Drug Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Boron-containing Compounds Drug Sales by Region: 2021–2032
3.2.1 Global Boron-containing Compounds Drug Sales by Region: 2021–2026
3.2.2 Global Boron-containing Compounds Drug Sales by Region: 2027–2032
3.3 Global Boron-containing Compounds Drug Revenue by Region: 2021–2032
3.3.1 Global Boron-containing Compounds Drug Revenue by Region: 2021–2026
3.3.2 Global Boron-containing Compounds Drug Revenue by Region: 2027–2032
3.4 North America Boron-containing Compounds Drug Market Facts & Figures by Country
3.4.1 North America Boron-containing Compounds Drug Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Boron-containing Compounds Drug Sales by Country (2021–2032)
3.4.3 North America Boron-containing Compounds Drug Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Boron-containing Compounds Drug Market Facts & Figures by Country
3.5.1 Europe Boron-containing Compounds Drug Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Boron-containing Compounds Drug Sales by Country (2021–2032)
3.5.3 Europe Boron-containing Compounds Drug Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Boron-containing Compounds Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Boron-containing Compounds Drug Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Boron-containing Compounds Drug Sales by Region (2021–2032)
3.6.3 Asia Pacific Boron-containing Compounds Drug Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Boron-containing Compounds Drug Market Facts & Figures by Country
3.7.1 Latin America Boron-containing Compounds Drug Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Boron-containing Compounds Drug Sales by Country (2021–2032)
3.7.3 Latin America Boron-containing Compounds Drug Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Boron-containing Compounds Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Boron-containing Compounds Drug Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Boron-containing Compounds Drug Sales by Country (2021–2032)
3.8.3 Middle East and Africa Boron-containing Compounds Drug Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Boron-containing Compounds Drug Sales by Type (2021–2032)
4.1.1 Global Boron-containing Compounds Drug Sales by Type (2021–2026)
4.1.2 Global Boron-containing Compounds Drug Sales by Type (2027–2032)
4.1.3 Global Boron-containing Compounds Drug Sales Market Share by Type (2021–2032)
4.2 Global Boron-containing Compounds Drug Revenue by Type (2021–2032)
4.2.1 Global Boron-containing Compounds Drug Revenue by Type (2021–2026)
4.2.2 Global Boron-containing Compounds Drug Revenue by Type (2027–2032)
4.2.3 Global Boron-containing Compounds Drug Revenue Market Share by Type (2021–2032)
4.3 Global Boron-containing Compounds Drug Price by Type (2021–2032)
5 Segment by Application
5.1 Global Boron-containing Compounds Drug Sales by Application (2021–2032)
5.1.1 Global Boron-containing Compounds Drug Sales by Application (2021–2026)
5.1.2 Global Boron-containing Compounds Drug Sales by Application (2027–2032)
5.1.3 Global Boron-containing Compounds Drug Sales Market Share by Application (2021–2032)
5.2 Global Boron-containing Compounds Drug Revenue by Application (2021–2032)
5.2.1 Global Boron-containing Compounds Drug Revenue by Application (2021–2026)
5.2.2 Global Boron-containing Compounds Drug Revenue by Application (2027–2032)
5.2.3 Global Boron-containing Compounds Drug Revenue Market Share by Application (2021–2032)
5.3 Global Boron-containing Compounds Drug Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Company Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Pharmaceutical Boron-containing Compounds Drug Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Janssen Pharmaceuticals
6.2.1 Janssen Pharmaceuticals Company Information
6.2.2 Janssen Pharmaceuticals Description and Business Overview
6.2.3 Janssen Pharmaceuticals Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Janssen Pharmaceuticals Boron-containing Compounds Drug Product Portfolio
6.2.5 Janssen Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer Boron-containing Compounds Drug Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Hovione FarmaCiencia
6.4.1 Hovione FarmaCiencia Company Information
6.4.2 Hovione FarmaCiencia Description and Business Overview
6.4.3 Hovione FarmaCiencia Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hovione FarmaCiencia Boron-containing Compounds Drug Product Portfolio
6.4.5 Hovione FarmaCiencia Recent Developments/Updates
6.5 Melinta Therapeutics
6.5.1 Melinta Therapeutics Company Information
6.5.2 Melinta Therapeutics Description and Business Overview
6.5.3 Melinta Therapeutics Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Melinta Therapeutics Boron-containing Compounds Drug Product Portfolio
6.5.5 Melinta Therapeutics Recent Developments/Updates
6.6 DC PHARMA
6.6.1 DC PHARMA Company Information
6.6.2 DC PHARMA Description and Business Overview
6.6.3 DC PHARMA Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 DC PHARMA Boron-containing Compounds Drug Product Portfolio
6.6.5 DC PHARMA Recent Developments/Updates
6.7 Gao Jin Biology
6.7.1 Gao Jin Biology Company Information
6.7.2 Gao Jin Biology Description and Business Overview
6.7.3 Gao Jin Biology Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Gao Jin Biology Boron-containing Compounds Drug Product Portfolio
6.7.5 Gao Jin Biology Recent Developments/Updates
6.8 Neuboron
6.8.1 Neuboron Company Information
6.8.2 Neuboron Description and Business Overview
6.8.3 Neuboron Boron-containing Compounds Drug Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Neuboron Boron-containing Compounds Drug Product Portfolio
6.8.5 Neuboron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Boron-containing Compounds Drug Industry Chain Analysis
7.2 Boron-containing Compounds Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Boron-containing Compounds Drug Production Mode & Process Analysis
7.4 Boron-containing Compounds Drug Sales and Marketing
7.4.1 Boron-containing Compounds Drug Sales Channels
7.4.2 Boron-containing Compounds Drug Distributors
7.5 Boron-containing Compounds Drug Customer Analysis
8 Boron-containing Compounds Drug Market Dynamics
8.1 Boron-containing Compounds Drug Industry Trends
8.2 Boron-containing Compounds Drug Market Drivers
8.3 Boron-containing Compounds Drug Market Challenges
8.4 Boron-containing Compounds Drug Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Boron-containing Compounds Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Boron-containing Compounds Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Boron-containing Compounds Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Boron-containing Compounds Drug Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Boron-containing Compounds Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Boron-containing Compounds Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Boron-containing Compounds Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Boron-containing Compounds Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Boron-containing Compounds Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Boron-containing Compounds Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Boron-containing Compounds Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Boron-containing Compounds Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Boron-containing Compounds Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Boron-containing Compounds Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Boron-containing Compounds Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Boron-containing Compounds Drug Sales by Region (Units), 2021–2026
Table 18. Global Boron-containing Compounds Drug Sales Market Share by Region (2021–2026)
Table 19. Global Boron-containing Compounds Drug Sales by Region (Units), 2027–2032
Table 20. Global Boron-containing Compounds Drug Sales Market Share by Region (2027–2032)
Table 21. Global Boron-containing Compounds Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Boron-containing Compounds Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Boron-containing Compounds Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Boron-containing Compounds Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Boron-containing Compounds Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Boron-containing Compounds Drug Sales by Country (Units), 2021–2026
Table 27. North America Boron-containing Compounds Drug Sales by Country (Units), 2027–2032
Table 28. North America Boron-containing Compounds Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Boron-containing Compounds Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Boron-containing Compounds Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Boron-containing Compounds Drug Sales by Country (Units), 2021–2026
Table 32. Europe Boron-containing Compounds Drug Sales by Country (Units), 2027–2032
Table 33. Europe Boron-containing Compounds Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Boron-containing Compounds Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Boron-containing Compounds Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Boron-containing Compounds Drug Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Boron-containing Compounds Drug Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Boron-containing Compounds Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Boron-containing Compounds Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Boron-containing Compounds Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Boron-containing Compounds Drug Sales by Country (Units), 2021–2026
Table 42. Latin America Boron-containing Compounds Drug Sales by Country (Units), 2027–2032
Table 43. Latin America Boron-containing Compounds Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Boron-containing Compounds Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Boron-containing Compounds Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Boron-containing Compounds Drug Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Boron-containing Compounds Drug Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Boron-containing Compounds Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Boron-containing Compounds Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Boron-containing Compounds Drug Sales (Units) by Type (2021–2026)
Table 51. Global Boron-containing Compounds Drug Sales (Units) by Type (2027–2032)
Table 52. Global Boron-containing Compounds Drug Sales Market Share by Type (2021–2026)
Table 53. Global Boron-containing Compounds Drug Sales Market Share by Type (2027–2032)
Table 54. Global Boron-containing Compounds Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Boron-containing Compounds Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Boron-containing Compounds Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Boron-containing Compounds Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Boron-containing Compounds Drug Sales (Units) by Application (2021–2026)
Table 61. Global Boron-containing Compounds Drug Sales (Units) by Application (2027–2032)
Table 62. Global Boron-containing Compounds Drug Sales Market Share by Application (2021–2026)
Table 63. Global Boron-containing Compounds Drug Sales Market Share by Application (2027–2032)
Table 64. Global Boron-containing Compounds Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Boron-containing Compounds Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Boron-containing Compounds Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Boron-containing Compounds Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2027–2032)
Table 70. Takeda Pharmaceutical Company Information
Table 71. Takeda Pharmaceutical Description and Business Overview
Table 72. Takeda Pharmaceutical Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Takeda Pharmaceutical Boron-containing Compounds Drug Product
Table 74. Takeda Pharmaceutical Recent Developments/Updates
Table 75. Janssen Pharmaceuticals Company Information
Table 76. Janssen Pharmaceuticals Description and Business Overview
Table 77. Janssen Pharmaceuticals Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Janssen Pharmaceuticals Boron-containing Compounds Drug Product
Table 79. Janssen Pharmaceuticals Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer Boron-containing Compounds Drug Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Hovione FarmaCiencia Company Information
Table 86. Hovione FarmaCiencia Description and Business Overview
Table 87. Hovione FarmaCiencia Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hovione FarmaCiencia Boron-containing Compounds Drug Product
Table 89. Hovione FarmaCiencia Recent Developments/Updates
Table 90. Melinta Therapeutics Company Information
Table 91. Melinta Therapeutics Description and Business Overview
Table 92. Melinta Therapeutics Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Melinta Therapeutics Boron-containing Compounds Drug Product
Table 94. Melinta Therapeutics Recent Developments/Updates
Table 95. DC PHARMA Company Information
Table 96. DC PHARMA Description and Business Overview
Table 97. DC PHARMA Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. DC PHARMA Boron-containing Compounds Drug Product
Table 99. DC PHARMA Recent Developments/Updates
Table 100. Gao Jin Biology Company Information
Table 101. Gao Jin Biology Description and Business Overview
Table 102. Gao Jin Biology Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Gao Jin Biology Boron-containing Compounds Drug Product
Table 104. Gao Jin Biology Recent Developments/Updates
Table 105. Neuboron Company Information
Table 106. Neuboron Description and Business Overview
Table 107. Neuboron Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Neuboron Boron-containing Compounds Drug Product
Table 109. Neuboron Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Boron-containing Compounds Drug Distributors List
Table 113. Boron-containing Compounds Drug Customers List
Table 114. Boron-containing Compounds Drug Market Trends
Table 115. Boron-containing Compounds Drug Market Drivers
Table 116. Boron-containing Compounds Drug Market Challenges
Table 117. Boron-containing Compounds Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Boron-containing Compounds Drug
Figure 2. Global Boron-containing Compounds Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Boron-containing Compounds Drug Market Share by Type: 2025 & 2032
Figure 4. Bortezomib Product Picture
Figure 5. Tavaborole Product Picture
Figure 6. Crisaborole Product Picture
Figure 7. Vaborbactam-Meropenem Product Picture
Figure 8. Ixazomib Product Picture
Figure 9. Others Product Picture
Figure 10. Global Boron-containing Compounds Drug Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Boron-containing Compounds Drug Market Share by Application: 2025 & 2032
Figure 12. Multiple Myeloma
Figure 13. Toenail Fungal Infection
Figure 14. Atopic Dermatitis
Figure 15. Others
Figure 16. Global Boron-containing Compounds Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Boron-containing Compounds Drug Market Size (US$ Million), 2021–2032
Figure 18. Global Boron-containing Compounds Drug Sales (Units), 2021–2032
Figure 19. Global Boron-containing Compounds Drug Average Price (US$/Unit), 2021–2032
Figure 20. Boron-containing Compounds Drug Report Years Considered
Figure 21. Boron-containing Compounds Drug Sales Share by Manufacturers in 2025
Figure 22. Global Boron-containing Compounds Drug Revenue Share by Manufacturers in 2025
Figure 23. Top 5 and Top 10 Global Boron-containing Compounds Drug Players: Market Share by Revenue in Boron-containing Compounds Drug in 2025
Figure 24. Boron-containing Compounds Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 25. Global Boron-containing Compounds Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 26. North America Boron-containing Compounds Drug Sales Market Share by Country (2021–2032)
Figure 27. North America Boron-containing Compounds Drug Revenue Market Share by Country (2021–2032)
Figure 28. United States Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Canada Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Europe Boron-containing Compounds Drug Sales Market Share by Country (2021–2032)
Figure 31. Europe Boron-containing Compounds Drug Revenue Market Share by Country (2021–2032)
Figure 32. Germany Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. France Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. U.K. Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Italy Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Russia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Asia Pacific Boron-containing Compounds Drug Sales Market Share by Region (2021–2032)
Figure 38. Asia Pacific Boron-containing Compounds Drug Revenue Market Share by Region (2021–2032)
Figure 39. China Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Japan Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. South Korea Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. India Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Australia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. China Taiwan Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Southeast Asia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Latin America Boron-containing Compounds Drug Sales Market Share by Country (2021–2032)
Figure 47. Latin America Boron-containing Compounds Drug Revenue Market Share by Country (2021–2032)
Figure 48. Mexico Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Brazil Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Argentina Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Colombia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Middle East and Africa Boron-containing Compounds Drug Sales Market Share by Country (2021–2032)
Figure 53. Middle East and Africa Boron-containing Compounds Drug Revenue Market Share by Country (2021–2032)
Figure 54. Turkey Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Saudi Arabia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. UAE Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Global Sales Market Share of Boron-containing Compounds Drug by Type (2021–2032)
Figure 58. Global Revenue Market Share of Boron-containing Compounds Drug by Type (2021–2032)
Figure 59. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2021–2032)
Figure 60. Global Sales Market Share of Boron-containing Compounds Drug by Application (2021–2032)
Figure 61. Global Revenue Market Share of Boron-containing Compounds Drug by Application (2021–2032)
Figure 62. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2021–2032)
Figure 63. Boron-containing Compounds Drug Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Boron-containing Compounds Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Boron-containing Compounds Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Boron-containing Compounds Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Boron-containing Compounds Drug Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Boron-containing Compounds Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Boron-containing Compounds Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Boron-containing Compounds Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Boron-containing Compounds Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Boron-containing Compounds Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Boron-containing Compounds Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Boron-containing Compounds Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Boron-containing Compounds Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Boron-containing Compounds Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Boron-containing Compounds Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Boron-containing Compounds Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Boron-containing Compounds Drug Sales by Region (Units), 2021–2026
Table 18. Global Boron-containing Compounds Drug Sales Market Share by Region (2021–2026)
Table 19. Global Boron-containing Compounds Drug Sales by Region (Units), 2027–2032
Table 20. Global Boron-containing Compounds Drug Sales Market Share by Region (2027–2032)
Table 21. Global Boron-containing Compounds Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Boron-containing Compounds Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Boron-containing Compounds Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Boron-containing Compounds Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Boron-containing Compounds Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Boron-containing Compounds Drug Sales by Country (Units), 2021–2026
Table 27. North America Boron-containing Compounds Drug Sales by Country (Units), 2027–2032
Table 28. North America Boron-containing Compounds Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Boron-containing Compounds Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Boron-containing Compounds Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Boron-containing Compounds Drug Sales by Country (Units), 2021–2026
Table 32. Europe Boron-containing Compounds Drug Sales by Country (Units), 2027–2032
Table 33. Europe Boron-containing Compounds Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Boron-containing Compounds Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Boron-containing Compounds Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Boron-containing Compounds Drug Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Boron-containing Compounds Drug Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Boron-containing Compounds Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Boron-containing Compounds Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Boron-containing Compounds Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Boron-containing Compounds Drug Sales by Country (Units), 2021–2026
Table 42. Latin America Boron-containing Compounds Drug Sales by Country (Units), 2027–2032
Table 43. Latin America Boron-containing Compounds Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Boron-containing Compounds Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Boron-containing Compounds Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Boron-containing Compounds Drug Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Boron-containing Compounds Drug Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Boron-containing Compounds Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Boron-containing Compounds Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Boron-containing Compounds Drug Sales (Units) by Type (2021–2026)
Table 51. Global Boron-containing Compounds Drug Sales (Units) by Type (2027–2032)
Table 52. Global Boron-containing Compounds Drug Sales Market Share by Type (2021–2026)
Table 53. Global Boron-containing Compounds Drug Sales Market Share by Type (2027–2032)
Table 54. Global Boron-containing Compounds Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Boron-containing Compounds Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Boron-containing Compounds Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Boron-containing Compounds Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Boron-containing Compounds Drug Sales (Units) by Application (2021–2026)
Table 61. Global Boron-containing Compounds Drug Sales (Units) by Application (2027–2032)
Table 62. Global Boron-containing Compounds Drug Sales Market Share by Application (2021–2026)
Table 63. Global Boron-containing Compounds Drug Sales Market Share by Application (2027–2032)
Table 64. Global Boron-containing Compounds Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Boron-containing Compounds Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Boron-containing Compounds Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Boron-containing Compounds Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2027–2032)
Table 70. Takeda Pharmaceutical Company Information
Table 71. Takeda Pharmaceutical Description and Business Overview
Table 72. Takeda Pharmaceutical Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Takeda Pharmaceutical Boron-containing Compounds Drug Product
Table 74. Takeda Pharmaceutical Recent Developments/Updates
Table 75. Janssen Pharmaceuticals Company Information
Table 76. Janssen Pharmaceuticals Description and Business Overview
Table 77. Janssen Pharmaceuticals Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Janssen Pharmaceuticals Boron-containing Compounds Drug Product
Table 79. Janssen Pharmaceuticals Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer Boron-containing Compounds Drug Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Hovione FarmaCiencia Company Information
Table 86. Hovione FarmaCiencia Description and Business Overview
Table 87. Hovione FarmaCiencia Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hovione FarmaCiencia Boron-containing Compounds Drug Product
Table 89. Hovione FarmaCiencia Recent Developments/Updates
Table 90. Melinta Therapeutics Company Information
Table 91. Melinta Therapeutics Description and Business Overview
Table 92. Melinta Therapeutics Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Melinta Therapeutics Boron-containing Compounds Drug Product
Table 94. Melinta Therapeutics Recent Developments/Updates
Table 95. DC PHARMA Company Information
Table 96. DC PHARMA Description and Business Overview
Table 97. DC PHARMA Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. DC PHARMA Boron-containing Compounds Drug Product
Table 99. DC PHARMA Recent Developments/Updates
Table 100. Gao Jin Biology Company Information
Table 101. Gao Jin Biology Description and Business Overview
Table 102. Gao Jin Biology Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Gao Jin Biology Boron-containing Compounds Drug Product
Table 104. Gao Jin Biology Recent Developments/Updates
Table 105. Neuboron Company Information
Table 106. Neuboron Description and Business Overview
Table 107. Neuboron Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Neuboron Boron-containing Compounds Drug Product
Table 109. Neuboron Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Boron-containing Compounds Drug Distributors List
Table 113. Boron-containing Compounds Drug Customers List
Table 114. Boron-containing Compounds Drug Market Trends
Table 115. Boron-containing Compounds Drug Market Drivers
Table 116. Boron-containing Compounds Drug Market Challenges
Table 117. Boron-containing Compounds Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Boron-containing Compounds Drug
Figure 2. Global Boron-containing Compounds Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Boron-containing Compounds Drug Market Share by Type: 2025 & 2032
Figure 4. Bortezomib Product Picture
Figure 5. Tavaborole Product Picture
Figure 6. Crisaborole Product Picture
Figure 7. Vaborbactam-Meropenem Product Picture
Figure 8. Ixazomib Product Picture
Figure 9. Others Product Picture
Figure 10. Global Boron-containing Compounds Drug Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Boron-containing Compounds Drug Market Share by Application: 2025 & 2032
Figure 12. Multiple Myeloma
Figure 13. Toenail Fungal Infection
Figure 14. Atopic Dermatitis
Figure 15. Others
Figure 16. Global Boron-containing Compounds Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Boron-containing Compounds Drug Market Size (US$ Million), 2021–2032
Figure 18. Global Boron-containing Compounds Drug Sales (Units), 2021–2032
Figure 19. Global Boron-containing Compounds Drug Average Price (US$/Unit), 2021–2032
Figure 20. Boron-containing Compounds Drug Report Years Considered
Figure 21. Boron-containing Compounds Drug Sales Share by Manufacturers in 2025
Figure 22. Global Boron-containing Compounds Drug Revenue Share by Manufacturers in 2025
Figure 23. Top 5 and Top 10 Global Boron-containing Compounds Drug Players: Market Share by Revenue in Boron-containing Compounds Drug in 2025
Figure 24. Boron-containing Compounds Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 25. Global Boron-containing Compounds Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 26. North America Boron-containing Compounds Drug Sales Market Share by Country (2021–2032)
Figure 27. North America Boron-containing Compounds Drug Revenue Market Share by Country (2021–2032)
Figure 28. United States Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Canada Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Europe Boron-containing Compounds Drug Sales Market Share by Country (2021–2032)
Figure 31. Europe Boron-containing Compounds Drug Revenue Market Share by Country (2021–2032)
Figure 32. Germany Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. France Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. U.K. Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Italy Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Russia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Asia Pacific Boron-containing Compounds Drug Sales Market Share by Region (2021–2032)
Figure 38. Asia Pacific Boron-containing Compounds Drug Revenue Market Share by Region (2021–2032)
Figure 39. China Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Japan Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. South Korea Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. India Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Australia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. China Taiwan Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Southeast Asia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Latin America Boron-containing Compounds Drug Sales Market Share by Country (2021–2032)
Figure 47. Latin America Boron-containing Compounds Drug Revenue Market Share by Country (2021–2032)
Figure 48. Mexico Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Brazil Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Argentina Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Colombia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Middle East and Africa Boron-containing Compounds Drug Sales Market Share by Country (2021–2032)
Figure 53. Middle East and Africa Boron-containing Compounds Drug Revenue Market Share by Country (2021–2032)
Figure 54. Turkey Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Saudi Arabia Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. UAE Boron-containing Compounds Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Global Sales Market Share of Boron-containing Compounds Drug by Type (2021–2032)
Figure 58. Global Revenue Market Share of Boron-containing Compounds Drug by Type (2021–2032)
Figure 59. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2021–2032)
Figure 60. Global Sales Market Share of Boron-containing Compounds Drug by Application (2021–2032)
Figure 61. Global Revenue Market Share of Boron-containing Compounds Drug by Application (2021–2032)
Figure 62. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2021–2032)
Figure 63. Boron-containing Compounds Drug Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232